Does Tirzepatide Cause Depression?

No, the available evidence does not show that tirzepatide causes depression. In the large clinical trials that led to its approval, depression and depressed mood were reported at rates similar to placebo, and US and European regulators have not confirmed a causal link between GLP-1 medications and depression or suicidal thoughts. That said, a small number of people do report mood changes after starting treatment, and those reports are worth taking seriously rather than dismissing.

What Clinical Trials and Regulators Say

Tirzepatide is the active ingredient in Mounjaro, approved for type 2 diabetes, and Zepbound, approved for weight management. Its registration trials — the SURPASS program for diabetes and the SURMOUNT program for obesity — tracked psychiatric side effects alongside the usual nausea and injection-site reactions.

• Depression-related events were uncommon and broadly balanced between the tirzepatide and placebo groups.
• None of those trials was designed specifically to detect depression, so very rare effects could still slip through.
• In 2024, the FDA and the European Medicines Agency reviewed GLP-1 receptor agonists for suicidal thoughts and behavior. Neither agency found evidence that the drugs cause these events, though both said they would keep monitoring.

Tirzepatide is not approved to treat depression, and it is not a known cause of depression in the clinical trial data.

Why Some People Still Report Mood Changes

Case reports and patient forums describe low mood, irritability, or emotional flatness after starting tirzepatide. Those reports are real, but they do not prove that the drug is responsible. Several indirect pathways could explain them.

• Rapid weight loss: Dropping 15 to 20 percent of body weight shifts hormones, energy, and body image all at once, and that transition can feel destabilizing.
• Changes in eating: Appetite suppression removes a coping habit some people relied on, which can bring difficult emotions to the surface.
• Blood sugar swings: Low blood sugar can trigger anxiety, confusion, and mood dips, especially for people also taking insulin or sulfonylureas.
• Sleep and GI side effects: Nausea, reflux, and constipation can wear anyone down. Poor sleep can mimic or worsen depression, and the question does tirzepatide cause insomnia comes up for the same reason.
• Life circumstances: Depression is common in the general population, so some cases simply appear during treatment rather than because of it.

People who notice restlessness often ask does tirzepatide cause anxiety as well, since anxiety and depression frequently travel together. If you typed can tirzepatide cause depression into a search bar, you are asking a question regulators have already examined at scale.

Tirzepatide vs. Semaglutide: How Mood-Related Reports Compare

The related question does semaglutide cause depression has drawn similar regulatory attention, and the conclusions have been comparable. The table below summarizes how the two drugs stack up on mood-related signals.

Factor	Tirzepatide (Mounjaro, Zepbound)	Semaglutide (Ozempic, Wegovy)
Drug class	Dual GIP and GLP-1 receptor agonist	GLP-1 receptor agonist
Depression signal in trials	No consistent increase vs. placebo	No consistent increase vs. placebo
Regulatory review of suicidal thoughts	No confirmed causal link	No confirmed causal link
Postmarketing mood reports	Rare reports of low mood or irritability	Rare reports of low mood or irritability
Indirect mood triggers	Nausea, fatigue, appetite loss, sleep changes	Nausea, fatigue, appetite loss, sleep changes

Neither medication carries a boxed warning for depression in the United States, and neither is considered a depressant drug.

Who Should Be More Careful

Some groups may be more vulnerable to mood changes during treatment, whether or not the drug is the direct cause.

• People with a personal or family history of depression, bipolar disorder, or anxiety.
• Anyone who has had mood symptoms on a previous GLP-1 medication.
• People with a history of eating disorders, for whom appetite changes can be psychologically loaded.
• Those taking insulin, sulfonylureas, or psychiatric medications that could interact with blood sugar or absorption.

Anyone with a history of depression should talk with their prescriber before starting tirzepatide, and should keep that conversation going during dose increases.

What to Do If You Feel Depressed on Tirzepatide

1. Tell your prescriber promptly. Do not wait for your next scheduled refill visit to mention new or worsening mood symptoms.
2. Do not stop the medication abruptly on your own. Your clinician can adjust the dose, switch drugs, or taper safely.
3. Track your symptoms. Note when they started, how severe they are, and whether they line up with dose changes or blood sugar swings.
4. Get mental health support. Therapy, support groups, and — when appropriate — medication for depression are legitimate parts of a treatment plan.
5. Seek urgent help for safety concerns. If you have thoughts of harming yourself, call or text 988 in the US or go to an emergency room right away.

The Bottom Line

Tirzepatide has not been shown to cause depression in controlled trials, and regulators have found no confirmed link between GLP-1 drugs and depression or suicidal thoughts. Individual mood changes can still happen, often through indirect routes such as rapid weight loss, poor sleep, or blood sugar swings. The safest approach is to start treatment with your prescriber informed about your mental health history and to report any mood changes early.

COMMON QUESTIONS

Frequently Asked Questions

Does tirzepatide cause depression?

Clinical trials of tirzepatide did not show higher rates of depression than placebo, and the FDA has not confirmed that GLP-1 medications cause depression. A small number of people report low mood after starting treatment, but those reports do not establish cause and effect. Anyone with new or worsening mood symptoms should contact their prescriber.

Can tirzepatide make existing depression worse?

There is no consistent evidence that tirzepatide worsens depression, but people with a history of depression may be more sensitive to the indirect effects of rapid weight loss, appetite changes, and poor sleep. Tell your prescriber about any past or current depression before starting. If symptoms intensify, your clinician can adjust the dose or change the treatment plan.

How common are mood side effects with tirzepatide?

Mood-related side effects appear to be uncommon in clinical trials, where depression and anxiety events were generally reported at similar rates to placebo. Postmarketing reports of low mood exist but are rare relative to the millions of prescriptions written. Nausea, fatigue, and sleep disruption, which can affect mood indirectly, are far more common.